Form 4: Invizyne Technologies Executive Reports Stock Transaction
Insider Transaction (Form 4)
Tyler Paz Korman, Chief Scientific Officer of Invizyne Technologies Inc, reported multiple transactions in common stock on August 19, 2026.
Summary
- Option exercise/conversion: acquired 32,964 Common Stock on August 19, 2026; holds 762,837 after (Direct).
- Option exercise/conversion: disposed of 32,964 Restricted Stock Unit on August 19, 2026; holds 46,140 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Tyler Paz Korman — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Option exercise/conversion | Common Stock | 32,964 | — | — | 762,837 |
| 2026-08-19 | Option exercise/conversion | Restricted Stock Unit | 32,964 | — | — | 46,140 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Option exercise/conversion (32,964 shares) |
| 2026-08-19 | Option exercise/conversion (32,964 shares) |
Keywords
insider transaction, Form 4, EXOZ, EXOZYMES INC., neutral, Tyler Paz Korman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.